40
Participants
Start Date
April 30, 2005
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Docetaxel
"Docetaxel 30 mg/m2 will be administered as a 30-minute infusion on days 1 and 8. Each cycle will consist of 21 days.~Cycle 2 will begin on day 22."
Capecitabine
"Capecitabine 825 mg/m2 bid (total daily dose 1650 mg/m2) will be administered orally for 14 days (days 1-14).~Each cycle will consist of 21 days.~Cycle 2 will begin on day 22."
University of Pittsburgh Medical Center, Pittsburgh
Collaborators (1)
Aventis Pharmaceuticals
INDUSTRY
Roche Pharma AG
INDUSTRY
University of Pittsburgh
OTHER